By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Kane Biotech Inc. 

6-1200 Waverley Street

Winnipeg  Manitoba  R3T 0P4  Canada
Phone: 204-487-7412 Fax: 204-488-9823




Company News
Kane Biotech Inc. (KNE) Announces Issuance Of Common Shares In Payment Of Outstanding Interest 12/31/2015 10:46:13 AM
Health Canada Approves Kane Biotech Inc. (KNE)'s DispersinB® For Human Use 7/23/2014 9:04:23 AM
Kane Biotech Inc. (KNE) Receives Approval from Health Canada for Hard Surface Disinfectant 10/12/2011 6:50:13 AM
Kane Biotech Inc. (KNE) Release: DispersinB(R) Wound Spray Passes Final Biocompatibility Sub-Chronic Toxicity Test 1/26/2011 10:31:47 AM
Kane Biotech Inc. (KNE) Announces Grant of Options 1/19/2011 10:12:45 AM
Kane Biotech Inc. (KNE) Retains Pure Advertising & Marketing for Investor Relations 1/13/2011 9:54:25 AM
Kane Biotech Inc. (KNE) Receives $100,000 in Financial Assistance from the Government of Manitoba 12/15/2010 9:43:26 AM
Kane Biotech Inc. (KNE) Issued US Patent for DispersinB(R) Wound Care Technology 11/16/2010 11:12:28 AM
Kane Biotech Inc. (KNE)'s DispersinB(R) Topical Wound Spray Passes Critical Sensitization Test 11/8/2010 9:54:00 AM
Kane Biotech Inc. (KNE) Appoints Board Advisor and Announces Private Placement Offering 11/2/2010 9:43:13 AM